Astrazeneca Pharma
May 18, 2012 at 11:55 | Source: Moneycontrol.com
May 16, 2012 at 12:24 | Source: Moneycontrol.com
May 15, 2012 at 15:50 | Source: Moneycontrol.com
Mar 29, 2012 at 15:36 | Source: Moneycontrol.com
Mar 28, 2012 at 13:15 | Source: Moneycontrol.com
Mar 13, 2012 at 14:54 | Source: Moneycontrol.com
News across the web »
May 23, 2012 at 11:57 | Source: FirstPost
May 21, 2012 at 13:38 | Source: Economic Times
May 18, 2012 at 22:51 | Source: FirstPost
May 18, 2012 at 22:51 | Source: FirstPost
May 18, 2012 at 02:32 | Source: Economic Times
Interact & exchange stock tips & market info »
Related News »
AstraZeneca Pharma gained as much as 8% on Friday to touch an intraday high of Rs 1,998 amid heavy volumes. At 11:46 hours IST, the share was trading at Rs 1,960, up 5.99%. It rallied 27% since yesterday, but before that it had been tanked 20% ...
May 18, 2012 at 06:25 | Source: MoneyControl.com
AstraZeneca Pharma India has tanked 7% to Rs 1,655 after reporting a net loss of Rs 33 crore during the fourth quarter ended March 31, due to a voluntary recall of sterile products and higher employee cost. The pharmaceutical company had a net profit of Rs ...
May 14, 2012 at 06:30 | Source: Business Standard
AstraZeneca has been under pressure for a while to improve ... significantly reduces R&D and sales and marketing to the same level as an average specialty pharma company, ie it becomes a specialty pharma company. If it adopts a specialty pharma-like ...
May 28, 2012 at 10:09 | Source: The Guardian
As new drug resistant superbugs such as the "New Delhi" bug have emerged, GlaxoSmithKline and AstraZeneca have teamed up with academics and other Big Pharma companies to tackle antibiotic resistance, which is becoming a major health threat around the world.
May 25, 2012 at 13:05 | Source: Phramalive.com
The Board of Directors of AstraZeneca Pharma India Ltd at its meeting held on May 11, 2012, has recommended a Dividend of Rs. 3.50/- per Equity Share of face value of Rs. 2/- each (175%) for the Financial Year ended March 31, 2012, subject to the approval ...
May 13, 2012 at 15:35 | Source: equitybulls.com
AstraZeneca has been inviting in companies to interview some of the exiting staffers, reports The Local, an English language news service. And the pharma giant is also offering advice to would-be entrepreneurs during "start-up days." Following a ...
May 14, 2012 at 23:55 | Source: FierceBiotech
As new drug resistant superbugs such as the "New Delhi" bug have emerged, GlaxoSmithKline and AstraZeneca have teamed up with academics and other Big Pharma companies to tackle antibiotic resistance, which is becoming a major health threat around the world.
May 25, 2012 at 09:23 | Source: Director of Finance online
AstraZeneca Pharma India spurted 20% on huge volumes. According to market buzz, UK-based AstraZeneca is planning to delist the Indian unit. Dish TV India rallied over 10% to Rs 61 on reporting a healthy 60% year-on-year (y-o-y) growth in standalone ...
May 17, 2012 at 10:44 | Source: Business Standard
AstraZeneca has one of the biggest sales teams in Mexico ... magical designs and innovative Pharma CRM solutions; under the brand name Sales Vision© Pharma CRM. Sales Vision© uses more than 45 different life-science companies in more than 40 countries ...
May 17, 2012 at 05:50 | Source: PRLog (free press release)
AstraZeneca R&D chief Martin Mackay isn't going to let ... reverse the fallout that's resulted from a series of pipeline setbacks which have left the pharma company ($AZN) in dire shape as it faces the patent cliff. That scenario forced David ...
May 20, 2012 at 23:55 | Source: FierceBiotech